Evidence map›Paper›PMID 32423001›Full record

ArticleInternational journal of molecular sciences2020

EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.

Marioara Chiritoiu, Gabriela N Chiritoiu, Cristian V A Munteanu, Florin Pastrama, N Erwin Ivessa, Stefana M Petrescu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Turnover of EDEM1, an ERAD-enhancing factor, is mediated by multiple degradation routes.Genes to cells : devoted to molecular & cellular mechanisms · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. YMolecules (Basel, Switzerland) · 2021
    Article
  17. EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning.International journal of molecular sciences · 2021
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marioara ChiritoiuDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0003-2064-2003
Gabriela N ChiritoiuDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-6321-6373
Cristian V A MunteanuDepartment of Bioinformatics & Structural Biochemistry, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.ORCID 0000-0002-2998-0458
Florin PastramaDepartment of Bioinformatics & Structural Biochemistry, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
N Erwin IvessaCenter for Medical Biochemistry, Max Perutz Labs, Medical University of Vienna, A-1030 Vienna, Austria.
Stefana M PetrescuDepartment of Molecular Cell Biology, Institute of Biochemistry, Splaiul Independentei 296, 060031 Bucharest 17, Romania.
Institute of Biochemistry · ROMax Perutz Labs · AT

Funding

European Social Fund SOP HRD/107/1.5/S/82514Herzfelder'sche Familienstiftung NEIRomanian Academy Project1/2020Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P1-1.1-PD- 2016-1528, PN-II-ID-PCE-2012-4-0350
6 · The paper itself

Abstract

Endoplasmic reticulum (ER)-associated degradation (ERAD) is the main mechanism of targeting ER proteins for degradation to maintain homeostasis, and perturbations of ERAD lead to pathological conditions. ER-degradation enhancing α-mannosidase-like (EDEM1) was proposed to extract terminally misfolded proteins from the calnexin folding cycle and target them for degradation by ERAD. Here, using mass-spectrometry and biochemical methods, we show that EDEM1 is found in auto-regulatory complexes with ERAD components. Moreover, the N-terminal disordered region of EDEM1 mediates protein-protein interaction with misfolded proteins, whilst the absence of this domain significantly impairs their degradation. We also determined that overexpression of EDEM1 can induce degradation, even when proteasomal activity is severely impaired, by promoting the formation of aggregates, which can be further degraded by autophagy. Therefore, we propose that EDEM1 maintains ER homeostasis and mediates ERAD client degradation via autophagy when either dislocation or proteasomal degradation are impaired.

Indexed as

ProteolysisAutophagyEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationHEK293 CellsHeLa CellsHumansMass SpectrometryMembrane ProteinsProteasome Endopeptidase ComplexProtein AggregatesProtein FoldingProtein Interaction MapsEDEM1 protein, humanMembrane ProteinsProteasome Endopeptidase ComplexProtein AggregatesautophagyEDEM1EDEM1 interaction networkendoplasmic reticulumERADER-phagyintrinsically disordered regionmass spectrometryprotein degradationprotein quality control

Identifiers

PMID32423001
PMCPMC7279049
OpenAlexW3024071240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.